Xiao Zhu

US Patent:

20230108298, Apr 6, 2023

Filed:

Sep 28, 2021

Appl. No.:

17/487190

Inventors:

- Atlanta GA, US
- Ann Arbor MI, US
Xiao Zhu - Ann Arbor MI, US

Assignee:

AT&T Intellectual Property I, L.P. - Atlanta GA
The Regents of the University of Michigan - Ann Arbor MI

International Classification:

H04L 29/06
H04L 12/26

Abstract:

Aspects of the subject disclosure may include, for example, obtaining and decoding a video file to obtain raw frames, providing the raw frames to the virtual camera that generates video content from the raw frames, providing the video content to a broadcasting application on a first communication device that provides output frames, and providing network conditions that are applied to the output frames resulting in conditioned output frames. The conditioned output frames are provided to a video content server from the first communication device, the video content server provides ABR tracks to a second communication device, the ABR tracks are associated with the conditioned output frames in response to receiving requests for the ABR tracks. Also, embodiments include obtaining and analyzing the conditioned output frames, the ABR tracks, and the requests, and generating metrics associated with the broadcasting application based on the analysis. Other embodiments are disclosed.

US Patent:

20180186799, Jul 5, 2018

Filed:

Jun 23, 2016

Appl. No.:

15/738362

Inventors:

- Princeton NJ, US
Joseph B. Santella - Springfield PA, US
Venkatram Reddy Paidi - Bangalore, Karnataka, IN
Hong Wu - New Hope PA, US
John V. Duncia - Newtown PA, US
Satheesh Kesavan Nair - Bangalore, Karnataka, IN
John Hynes - Washington Crossing PA, US
Xiao Zhu - Potomac MD, US

International Classification:

C07D 487/04
C07D 471/04

Abstract:

Disclosed are compounds of Formula (I) or salts thereof, wherein HET is a heteroaryl selected from pyrrolo[2,3-b]pyridinyl, pyrrolo[2,3 d]pyrimidinyl, pyrazolo[3,4 b]pyridinyl, pyrazolo[3,4 d]pyrimidinyl, imidazolo[4,5 b]pyridinyl, and imidazolo[4,5 d]pyrimidinyl, wherein said heteroaryl is attached to the pyridinyl group in the compound of Formula (I) by a nitrogen ring atom in said heteroaryl and wherein said heteroaryl is substituted with zero to 2 R; A is pyrazolyl, imidazolyl, triazolyl, isoxazolyl, oxadiazolyl or dihydroisoxazolyl, each substituted with zero or 1 R; and R, R, and Rare define herein. Also disclosed are methods of using such compounds as modulators of IRAK4, and pharmaceutical compositions comprising such compounds. These compounds are useful in treating, preventing, or slowing inflammatory and autoimmune diseases, or in the treatment of cancer.